Johnson & Johnson
NYSE: JNJ
$152.64
-$2.40 (-1.5%)
Closing Price on November 12, 2024
JNJ Articles
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and...
Published:
Johnson & Johnson released better than expected quarterly results and hiked its dividend before the markets opened on Tuesday.
Published:
Johnson & Johnson is scheduled to release its fiscal first-quarter financial results before the markets open on Tuesday.
Published:
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Johnson & Johnson and JPMorgan.
Published:
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Published:
Sometimes it's just the relative performance that really matters to investors. Imagine saying, "Gee, that's great because it's only down 10% in this awful stock market."
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published:
Investors have not shaved a tremendous amount of value from mega-cap public corporations. Two American companies still have market caps above $1 trillion.
Published:
Monday's blowout lows have more or less created a bear market on the average mega-cap stock. 24/7 Wall St. wanted to review the top 10 components of the S&P 500 Index by market capitalization to see...
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Published:
With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks appear to be undervalued against the performance of the broader markets.
Published:
With more than 60,000 reported cases of the coronavirus and nearly 1,400 deaths worldwide along with quarantines and travel restrictions, the impact of the disease on global GDP is just beginning to...
Published:
Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and investors have reacted coolly to guidance.
Published:
24/7 Wall St. has put together a preview of American Express, Intel, Procter & Gamble and the other Dow companies scheduled to report their quarterly results this week.
Published:
Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline expectation of more than 7% gains in 2020.
Published: